Literature DB >> 825532

Gonococci causing disseminated gonococcal infection are resistant to the bactericidal action of normal human sera.

G K Schoolnik, T M Buchanan, K K Holmes.   

Abstract

The susceptibility of strains of Neisseria gonorrhoeae to the bactericidal action of normal human sera was determined for isolates from patients with disseminated gonococcal infection and uncomplicated gonorrhea. Serum susceptibility was correlated with penicillin susceptibility and auxotype. 38 of 39 strains (97%) of N. gonorrhoeae from Seattle patients with disseminated gonococcal infection were resistant to the complement-dependent bactericidal action of normal human sera. 36 of these were inhibited by less than or equal to mug/ml of penicillin G and required arginine, hypoxanthine, and uracil for growth on chemically defined medium (Arg-Hyx-Ura- auxotype). 12 of 43 isolates from patients with uncomplicated gonorrhea were also of the Arg-Hyx-Ura-auxotype, inhibited by less than or equal to 0.030 mug/ml of penicillin G, and serum resistant. Of the 31 remaining strains of other auxotypes isolated from patients with uncomplicated gonorrhea, 18 (58.1%) were sensitive to normal human sera in titers ranging from 2 to 2,048. The bactericidal action of normal human sera may prevent the dissemination of serum-sensitive gonococci. However, since only a small proportion of individuals infected by serum-resistant strains develop disseminated gonococcal infection, serum resistance appears to be a necessary but not a sufficient virulence factor for dissemination. Host factors such as menstruation and pharyngeal gonococcal infection may favor the dissemination of serum-resistant strains. Since serum-resistant Arg-Hyx-Ura strains are far more frequently isolated from patients with disseminated gonococcal infection than serum-resistant strains of other auxotypes, Arg-Hyx-Ura-strains may possess other virulence factors in addition to serum resistance.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 825532      PMCID: PMC333284          DOI: 10.1172/JCI108569

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  Homozygous deficiency of C3 in a patient with repeated infections.

Authors:  C A Alper; H R Colten; F S Rosen; A R Rabson; G M Macnab; J S Gear
Journal:  Lancet       Date:  1972-12-02       Impact factor: 79.321

Review 2.  Primary immunodeficiencies. Report of a World Health Organization Committee.

Authors:  H Fudenberg; R A Good; H C Goodman; W Hitzig; H G Kunkel; I M Roitt; F S Rosen; D S Rowe; M Seligmann; J R Soothill
Journal:  Pediatrics       Date:  1971-05       Impact factor: 7.124

3.  Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3).

Authors:  C A Alper; N Abramson; R B Johnston; J H Jandl; F S Rosen
Journal:  N Engl J Med       Date:  1970-02-12       Impact factor: 91.245

4.  Genetic aspects of diseases of complement: an explosion.

Authors:  M J Polley; A G Bearn
Journal:  Am J Med       Date:  1975-01       Impact factor: 4.965

5.  Cross-reactivity of Neisseria gonorrhoeae and Neisseria meningitidis and the nature of antigens involved in the bactericidal reaction.

Authors:  E C Tramont; J C Sadoff; M S Artenstein
Journal:  J Infect Dis       Date:  1974-09       Impact factor: 5.226

6.  Maintenance of virulent gonococci in laboratory culture.

Authors:  P J Watt; A A Glynn; M E Ward
Journal:  Nat New Biol       Date:  1972-04-12

7.  NEISSERIA GONORRHOEAE IDENTIFICATION IN DIRECT SMEARS BY A FLUORESCENT ANTIBODY-COUNTERSTAIN METHOD.

Authors:  L A WHITE; D S KELLOGG
Journal:  Appl Microbiol       Date:  1965-03

8.  Induction of Haemophilus influenzae type b capsular antibody in neonatal rabbits by gastrointestinal colonization with cross-reacting Escherichia coli.

Authors:  R L Myerowitz; Z T Handzel; R Scheerson; J B Robbins
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

9.  Neisseria gonorrhoeae auxotyping: differentiation of clinical isolates based on growth responses on chemically defined media.

Authors:  K Carifo; B W Catlin
Journal:  Appl Microbiol       Date:  1973-09

10.  Studies on gonococcus infection. 3. Correlation of gonococcal colony morphology with infectivity for the chick embryo.

Authors:  T M Buchanan; E C Gotschlich
Journal:  J Exp Med       Date:  1973-01-01       Impact factor: 14.307

View more
  86 in total

1.  Pharyngeal neisseria gonorrhoeae: coloniser or pathogen?

Authors:  J Wallin; M S Siegel
Journal:  Br Med J       Date:  1979-06-02

2.  Plaque assay for measuring serum bactericidal activity against gonococci.

Authors:  L B Corbeil; A C Wunderlich; J I Ito; J A McCutchan
Journal:  J Clin Microbiol       Date:  1978-11       Impact factor: 5.948

3.  Internal medicine-epitomes of progress: characteristics of gonococci which disseminate in the blood.

Authors:  J A McCutchan
Journal:  West J Med       Date:  1978-07

4.  Experimental transmission of Neisseria gonorrhoeae from pregnant rat to fetus.

Authors:  S Nowicki; R Selvarangan; G Anderson
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 5.  Systemic gonococcal infection.

Authors:  J D Ross
Journal:  Genitourin Med       Date:  1996-12

6.  Role of iron in disseminated gonococcal infections.

Authors:  S M Payne; K K Holmes; R A Finkelstein
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

7.  Differences in susceptibilities of the lymphogranuloma venereum and trachoma biovars of Chlamydia trachomatis to neutralization by immune sera.

Authors:  E M Peterson; M Hoshiko; B A Markoff; M W Lauermann; L M de la Maza
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

8.  Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from lactoferrin.

Authors:  P A Mickelsen; E Blackman; P F Sparling
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

9.  Increased serum resistance in Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases.

Authors:  H Sahly; H Aucken; V J Benedí; C Forestier; V Fussing; D S Hansen; I Ofek; R Podschun; D Sirot; J M Tomás; D Sandvang; U Ullmann
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

10.  Molecular characterization of the argJ mutation in Neisseria gonorrhoeae strains with requirements for arginine, hypoxanthine, and uracil.

Authors:  P R Martin; M H Mulks
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.